Literature DB >> 17011827

Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.

Elvira Rubakova1, Svetlana Petrovskaya, Alexander Pichugin, Valentine Khlebnikov, David McMurray, Elena Kondratieva, Irina Baturina, Tatiana Kondratieva, Alexander Apt.   

Abstract

Dendritic cells (DC) likely play important and unique roles in the generation of protective immunity to mycobacteria. In order to clarify their contributions, bone marrow-derived DC loaded with Mycobacterium tuberculosis sonicate antigens were used to stimulate T cell proliferation both in vitro and in vivo and to vaccinate C57BL/6 mice against subsequent challenge with virulent mycobacteria. Antigen-pulsed DC developed in fetal calf serum (FCS-DC), but not DC developed in normal mouse serum (NMS-DC), stimulated significant proliferation of both naïve and immune T cells in vitro. The difference between cell populations developed in FCS and NMS in the content of CD11c(+) cells and in production of key cytokines indicated that NMS is less supportive for the development of activated DC. However, following adoptive transfer of a single dose of antigen-pulsed DC into naive recipients, NMS-DC induced T cells that proliferated in response to mycobacterial antigen, whereas FCS-DC stimulated strong non-specific proliferation. Vaccination with two doses of antigen-pulsed NMS-DC by the subcutaneous route induced significant protection against intravenous challenge with a moderate dose of virulent M. tuberculosis. DC-vaccinated mice exhibited significant reductions in bacillary loads in the lungs and spleens, and markedly reduced lung pathology. Three doses of antigen-pulsed NMS-DC induced a significant increase in survival time following high dose challenge, which correlated with a significant increase in IFN-gamma-producing cells in both lung and lymphoid tissues, as assessed by the ELISPOT assay. Taken together, these results indicate that DC play a critical role in the induction of protective resistance against virulent mycobacterial challenge accompanied by the development of antigen-reactive, IFN-gamma-producing T cells, and that their antigenic specificity is influenced by the culture conditions under which the DC are developed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011827     DOI: 10.1016/j.tube.2006.06.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  5 in total

Review 1.  The role of dendritic cells in mycobacterium-induced granulomas.

Authors:  Heidi A Schreiber; Matyas Sandor
Journal:  Immunol Lett       Date:  2010-01-04       Impact factor: 3.685

2.  Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice.

Authors:  Han-Gyu Choi; Seunga Choi; Yong Woo Back; Seungwha Paik; Hye-Soo Park; Woo Sik Kim; Hongmin Kim; Seung Bin Cha; Chul Hee Choi; Sung Jae Shin; Hwa-Jung Kim
Journal:  Oncotarget       Date:  2017-03-21

Review 3.  Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion.

Authors:  Hongmin Kim; Sung Jae Shin
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

4.  Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells.

Authors:  Nasir Salam; Shashank Gupta; Sachin Sharma; Shweta Pahujani; Aprajita Sinha; Rajiv K Saxena; Krishnamurthy Natarajan
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

5.  Antigen-presenting cells transfected with Hsp65 messenger RNA fail to treat experimental tuberculosis.

Authors:  C D Rocha; A P F Trombone; J C C Lorenzi; L P Almeida; A F Gembre; E Padilha; S G Ramos; C L Silva; A A M Coelho-Castelo
Journal:  Braz J Med Biol Res       Date:  2012-09-18       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.